全球器官保存市场规模（依保存技术、器官类型、最终用户、地区、范围和预测）

器官保存市场规模及预测

2024 年器官保存市场规模价值为 2.5934 亿美元，预计到 2032 年将达到 4.1424 亿美元，2026 年至 2032 年的复合年增长率为 6.65%。

器官保存是指确保用于移植或研究的器官的活力和功能性的策略和方法。器官保存至关重要，因为器官从捐赠者体内取出后必须保持良好状态，以避免器官劣化，并在移植到接受者体内时保持正常功能。

器官保存是移植医学中的重要技术，旨在保持器官在移植过程中的活力和功能。器官保存的主要应用包括肝臟、肾臟、心臟、肺部和胰臟移植。为了提高器官在运输和储存过程中的存活率，器官保存策略包括静态低温保存、低温灌注和常温灌注。

随着技术突破和研究进展，器官保存的未来前景一片光明。诸如体内保存以及使用合成培养基在高温下保存器官等新技术正在被研究，以延长保存时间并提高器官品质。

全球器官保存市场动态

关键市场驱动因素

器官移植率不断提升：随着糖尿病、高血压和肝病等慢性疾病导致器官衰竭的发生率不断上升，器官移植的需求也将随之成长。随着寻求器官移植的人数不断增加，对高效能器官保存策略的需求也将随之成长。提高移植成功率将促使医院和医疗机构投资更先进的器官保存技术，进而推动市场扩张。

器官保存技术的进步：低温灌注和强化冷冻保存等器官保存技术的创新，提高了器官的存活率，并延长了储存和运输过程中的寿命。这些进展提高了移植的成功率，并使器官保存技术对医护人员更具吸引力。

政府倡议和意识提升计画：世界各国政府和组织越来越认识到器官捐赠和器官保存的价值。旨在提高器官捐赠意识、提高捐赠率并引入改进的器官保存方法的倡议正日益增多。这些计画不仅鼓励更多人註册成为器官捐赠者，也促进了现代器官保存技术在医疗保健领域的应用。

主要挑战

器官供应有限：器官保存面临的最大问题之一是适当的移植器官短缺。儘管器官保存方法不断进步，但器官供需之间仍存在巨大缺口。捐赠者资质、公众认知以及器官捐赠的文化观念等因素加剧了这个问题。

技术限制：冷藏和低温灌注等器官保存技术虽然取得了进展，但仍有其限制。这些技术只能在有限的时间内延长器官存活时间，并增加了缺血和细胞损伤的风险。

监管与合规问题：器官保存产业受到严格监管，对所使用的技术和产品都有严格的标准。对于企业而言，遵守这些法规可能既困难又耗时，从而减缓新技术的采用并增加营运成本。遵守这些标准对于市场参与企业至关重要，但对于中小型企业而言，遵守这些标准可能并非易事。

主要趋势：

技术进步：低温机械灌注和常温局部灌注等新的器官保存技术正在提高移植器官的存活率。这些创新技术不仅延长了器官的保存时间，也改善了移植后器官的功能。

器官移植需求日益增长：随着糖尿病和肝硬化等慢性疾病的日益普遍，器官移植的需求也日益增长。随着等待器官移植的人数不断增加，有效的器官保存措施变得越来越重要。这一趋势推动了对器官移植研发的投入，旨在改善器官保存技术，以满足日益增长的需求。

监管支持和倡议：各国政府和卫生组织正在推出鼓励器官捐赠和移植的计画。监管机构也在製定规则，鼓励使用先进的器官保存技术。此类支持有助于改善器官保存方法，提高器官的可获得性，进而改善器官移植的整体情况。

目录

第一章 引言

• 市场定义
• 市场区隔
• 调查方法

第二章执行摘要

• 主要发现
• 市场概览
• 市集亮点

第三章市场概述

• 市场规模和成长潜力
• 市场趋势
• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析

第四章 器官保存市场（依保存技术）

• 概述
• 静态冷藏（SCS）
• 低温机灌注（HMP）
• 常温机械灌注（NMP）

第五章 器官保存市场（依器官类型）

• 概述
• 肾
• 肝
• 心
• 肺
• 胰臟
• 其他的

第六章 器官保存市场（依最终使用者）

• 概述
• 医院及移植中心
• 器官获取组织（OPO）
• 研究机构和研究中心

第七章区域分析

• 概述
• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东和非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯聯合大公国

第八章市场动态

• 市场驱动因素
• 市场限制
• 市场机会
• COVID-19 市场影响

第九章 竞争态势

• 主要企业
• 市场占有率分析

第十章 公司简介

• Overview
• XVIVO Perfusion
• TransMedics
• OrganOx Limited
• Franz Kohler Chemie GmbH
• Essential Pharmaceuticals LLC
• Preservation Solutions, Inc.
• BioLifeSolutions Inc.
• Bridge to Life Ltd.
• 21st Century Medicine
• Paragonix Technologies Inc

第十一章 市场展望与机会

• 新兴技术
• 未来市场趋势
• 投资机会

第十二章 附录

• 简称列表
• 来源和参考文献

Organ Preservation Market Size and Forecast

Organ Preservation Market size was valued at USD 259.34 Million in 2024 and is projected to reach USD 414.24 Million by 2032, growing at a CAGR of 6.65% from 2026 to 2032.

Organ preservation refers to the strategies and methods used to ensure the viability and functionality of organs for transplantation or study. This method is critical because organs must be kept in good condition after being removed from a donor to avoid deterioration and ensure they function properly when transplanted into a recipient.

It is a vital technique in transplantation medicine that aims to keep organs viable and functional for transplantation. The principal applications of organ preservation include liver, kidney, heart, lung, and pancreatic transplants. Various preservation strategies, including static cold storage, hypothermic machine perfusion, and normothermic machine perfusion are used to increase organ viability during transport and storage.

The future of organ preservation seems promising, thanks to technical breakthroughs and greater study. Emerging techniques such as biopreservation and the use of synthetic media to keep organs viable at higher temperatures are being investigated to prolong preservation times and improve organ quality.

Global Organ Preservation Market Dynamics

The key market dynamics that are shaping the global organ preservation market include:

Key Market Drivers:

Increasing Organ Transplantation Rates: As the frequency of organ failure from chronic diseases such as diabetes, hypertension, and liver disease rises so does the demand for organ transplants. As more people seek organ transplants, the necessity for efficient organ preservation strategies grows. Improved transplant success rates motivate hospitals and healthcare facilities to invest in enhanced preservation technologies which drives market expansion.

Advances in Preservation Technologies: Innovations in organ preservation technologies such as hypothermic machine perfusion and enhanced cryopreservation procedures have increased organ viability and longevity during storage and transport. These developments increase the likelihood of a successful transplant making preservation technology more enticing to healthcare professionals.

Government Initiatives and Awareness Programs: Governments and organizations around the world are increasingly realizing the value of organ donation and preservation. Initiatives to raise awareness about organ donation, increase donation rates, and introduce improved preservation procedures are becoming more common. Such programs not only encourage more people to register as organ donors but they also promote the use of modern preservation technology in healthcare settings.

Key Challenges:

Limited Availability of Organs: One of the most significant issues in organ preservation is the lack of suitable organs for transplantation. Despite advances in preservation procedures, there is still a considerable gap between organ demand and supply. Factors such as organ donor eligibility, public knowledge, and cultural views toward organ donation all worsen the problem.

Technological Limitations: Although organ preservation technologies like as cold storage and hypothermic machine perfusion have advanced, they are still limited. These techniques can only extend organ viability for a limited time increasing the risk of ischemia and cell damage.

Regulatory and Compliance Issues: The organ preservation industry is highly regulated with strict criteria governing the techniques and goods used. Navigating these restrictions can be difficult and time-consuming for businesses, potentially delaying the adoption of new technologies and increasing operational costs. Compliance with these standards is critical for market participants but it can be difficult, particularly for smaller companies.

Key Trends:

Technological Advancements: New organ preservation procedures such as hypothermic machine perfusion and normothermic regional perfusion are increasing the survivability of organs for transplantation. These innovative procedures not only increase the preservation period but also improve organ function after transplantation.

Increased Demand for Organ Transplants: As chronic diseases like diabetes and liver cirrhosis become more common, there is a greater demand for organ transplants. As waiting lists for organ transplants rise, effective preservation measures become increasingly important. This trend is pushing investment in R&D with a focus on improving organ preservation technologies to satisfy increasing demand.

Regulatory Support and Initiatives: Governments and health organizations are launching programs to encourage organ donation and transplantation. Regulators are also developing rules to encourage the use of advanced preservation technology. Such support improves the entire picture of organ transplantation by enabling better preservation methods and increasing organ availability.

Global Organ Preservation Market Regional Analysis

Here is a more detailed regional analysis of the global organ preservation market:

North America:

North America dominates the organ preservation market owing to its advanced healthcare infrastructure and high organ transplant rates. This dominance is reinforced by significant government financing, extensive research projects, and an established network of organ procurement groups. The United States leads in organ transplantation in North America, with the United Network for Organ Sharing (UNOS) reporting 41,354 organ transplants in 2021, up 5.9% from 2020.

According to data from the Organ Procurement and Transplantation Network (OPTN), there were 104,888 candidates on the national transplant waiting list in February 2023, highlighting the crucial need for organ preservation technology to maximize the viability of available organs. The U.S. Department of Health and Human Services reports that 17 people die each day waiting for an organ transplant emphasizing the urgency for advanced preservation methods to increase the pool of viable organs.

According to the Canadian Institute for Health Information, 2,782 organ transplants were performed in 2021, representing a 13% increase from 2020. The Canadian government has invested CAD 36.5 million over five years to improve the organ donation and transplantation system, which includes funding for preservation technologies.

Asia Pacific:

The rapidly increasing rate of organ transplants is the fastest-growing driver of the Asia Pacific organ preservation market. This acceleration is mostly owing to improved healthcare infrastructure, increased public awareness of organ donation, and government attempts to promote transplantation programs. In China, the number of organ transplants has significantly increased. The Commission also projected that the number of registered organ donors in China will reach 2.54 million by the end of 2020, up from 1,087 in 2010.

According to the National Organ and Tissue Transplant Organisation (NOTTO), the rate of organ donation in India has increased from 0.08 per million people in 2012 to 0.65 per million by 2021. Australia and New Zealand have also helped to drive regional growth, with the Australia and New Zealand Organ Donation Registry reporting 1,444 organ transplants in 2020, despite the pandemic's hurdles. These figures highlight the growing demand for effective organ preservation options in the Asia Pacific region. Furthermore, the World Health Organization estimates that the prevalence of chronic diseases, a primary driver of organ transplantation, will increase by 57% in the Asia Pacific region.

Global Organ Preservation Market: Segmentation Analysis

The Global Organ Preservation Market is segmented based on Preservation Technique, Organ Type, End-User, and Geography.

Organ Preservation Market, By Preservation Technique

• Static Cold Storage (SCS)
• Hypothermic Machine Perfusion (HMP
• Normothermic Machine Perfusion (NMP)

Based on the Preservation Technique, the Global Organ Preservation Market is bifurcated into Static Cold Storage (SCS), Hypothermic Machine Perfusion (HMP, Normothermic Machine Perfusion (NMP). In the global organ preservation market, static cold storage (SCS) remains the dominant technique due to its widespread acceptance and established protocols for preserving organs before transplantation. SCS is cost-effective, simple to implement, and requires minimal equipment making it accessible for many hospitals and transplant centers. It is particularly effective for short-term preservation of organs such as kidneys and livers.

Organ Preservation Market, By Organ Type

• Kidneys
• Liver
• Heart
• Lungs
• Pancreas
• Others

Based on the Organ Type, the Global Organ Preservation Market is bifurcated into Kidneys, Liver, and Heart, Lungs, Pancreas, Others. In the global organ preservation market, the kidneys segment is the dominant category. This dominance is primarily due to the high prevalence of kidney diseases including chronic kidney disease and end-stage renal failure which necessitate organ transplants. The increasing number of dialysis patients seeking transplants amplifies the demand for kidney preservation solutions. Additionally, advancements in preservation technologies such as hypothermic machine perfusion, enhance the viability and longevity of kidney transplants, further propelling this segment's growth.

Organ Preservation Market, By End-User

• Hospitals and Transplant Centres
• Organ Procurement Organizations
• Research Institutes and Laboratories

Based on the End-User, the Global Organ Preservation Market is bifurcated into Hospitals and Transplant Centres, Organ Procurement Organizations, Research Institutes and Laboratories. In the global organ preservation market, hospitals and transplant centers are the dominant end-users. This dominance stems from their central role in the organ transplantation process where the preservation of organs is critical for successful outcomes. Hospitals and transplant centers are equipped with specialized facilities and expertise to ensure optimal preservation conditions facilitating the timely transplantation of harvested organs. Moreover, the increasing number of organ transplant procedures due to rising organ failure rates and advancements in transplantation technologies further drive the demand for preservation solutions in these settings.

Organ Preservation Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on Geography, the Global Organ Preservation Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America is the dominant region in the global organ preservation market. This leadership is primarily attributed to advanced healthcare infrastructure, high rates of organ transplantation, and significant investments in research and development. The presence of key players and cutting-edge technologies further enhances the region's market position. Additionally, stringent regulations and standards governing organ preservation practices in North America drive innovation and ensure high-quality preservation solutions.

Key Players

The "Global Organ Preservation Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are XVIVO Perfusion, TransMedics, OrganOx Limited, Franz Kohler Chemie GmbH, Essential Pharmaceuticals LLC, Preservation Solutions, Inc., BioLifeSolutions, Inc., Bridge to Life Ltd., 21st Century Medicine, and Paragonix Technologies, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Organ Preservation Market Key Developments

• In August 2022, Paragonix Technologies, Inc. achieved a critical milestone by preserving over 2,000 donor organs while delivering Advanced Organ Preservation (AOPT) technology and a statewide clinical support network. Each of these systems incorporates novel preservation methods, considerably improving traditional ice and cooler processes.
• In January 2023, transplant surgeons at MedStar Georgetown University Hospital in the Washington Metropolitan area of the United States successfully utilized a new FDA-approved technology, the OrganOx metra, which simulates connecting a liver to its recipient, allowing the donated liver to be preserved for up to 12 hours before being transplanted into the recipient.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Organ Preservation Market, By Preservation Technique

• Overview
• Static Cold Storage (SCS)
• Hypothermic Machine Perfusion (HMP)
• Normothermic Machine Perfusion (NMP)

5. Organ Preservation Market, By Organ Type

• Overview
• Kidneys
• Liver
• Heart
• Lungs
• Pancreas
• Others

6. Organ Preservation Market, By End-User

• Overview
• Hospitals and Transplant Centers
• Organ Procurement Organizations (OPOs)
• Research Institutes and Laboratories

7. Regional Analysis

• Overview
• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Overview
• XVIVO Perfusion
• TransMedics
• OrganOx Limited
• Franz Kohler Chemie GmbH
• Essential Pharmaceuticals LLC
• Preservation Solutions, Inc.
• BioLifeSolutions Inc.
• Bridge to Life Ltd.
• 21st Century Medicine
• Paragonix Technologies Inc

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References